Literature DB >> 6895756

Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism.

S Y Wu, T P Shyh, I J Chopra, D H Solomon, H W Huang, P C Chu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6895756     DOI： 10.1210/jcem-54-3-630

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

2.  Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.

Authors:  E Martino; S Balzano; L Bartalena; A Loviselli; V Sica; L Petrini; L Grasso; M Piga; L E Braverman
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

3.  Inner-ring deiodination of 3,5,3'-triiodothyronine in the in situ perfused guinea pig placenta.

Authors:  M I Castro; L E Braverman; S Alex; C F Wu; C H Emerson
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

4.  Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.

Authors:  G Robuschi; A Manfredi; M Salvi; E Gardini; M Montermini; L d'Amato; E Borciani; L Negrotti; A Gnudi; E Roti
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  Dual mechanisms of regulation of type I iodothyronine 5'-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents.

Authors:  D L St Germain
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.